Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$520K Buy
+30,400
New +$564K ﹤0.01% 2495
2024
Q4
Sell
-18,200
Closed -$221K 3370
2024
Q3
$221K Buy
+18,200
New +$151K ﹤0.01% 1935
2024
Q2
Sell
-12,700
Closed -$97K 3239
2024
Q1
$97K Buy
+12,700
New +$123K ﹤0.01% 1857
2023
Q1
Sell
-40,400
Closed -$401K 3296
2022
Q4
$401K Buy
40,400
+29,400
+267% +$265K 0.01% 1569
2022
Q3
$131K Buy
+11,000
New +$237K ﹤0.01% 2327
2022
Q2
Sell
-33,400
Closed -$921K 3858
2022
Q1
$921K Buy
33,400
+25,200
+307% +$895K 0.01% 1130
2021
Q4
$412K Buy
+8,200
New +$370K ﹤0.01% 2046
2021
Q2
Sell
-49,700
Closed -$1.81M 3638
2021
Q1
$1.81M Buy
+49,700
New +$2.07M 0.02% 672

Other funds holding XPEV

HRT Financial's XPEV Position: Q4 2025 in Review

HRT Financial sold out of XPeng (XPEV) in Q4 2025, closing a stake of 189,946 shares — an estimated $4.45M sold.

HRT Financial first reported a position in XPEV in Q1 2021 and held it in 11 quarters. The position peaked at $15.6M in Q3 2023. 240 funds tracked by Wall St. Rank hold XPEV as of Q4 2025.

  • HRT Financial reported no remaining XPeng position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 189,946 XPeng shares in Q4 2025, an estimated $4.45M.
  • HRT Financial first reported a position in XPeng in Q1 2021 and held it in 11 quarters.
  • HRT Financial's XPeng position peaked at $15.6M in Q3 2023.
  • 240 funds tracked by Wall St. Rank held XPeng as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.